Safety and efficacy trial evaluating the use of SR34006 [idraparinux sodium] in the treatment of deep vein thrombosis (DVT).

Trial Profile

Safety and efficacy trial evaluating the use of SR34006 [idraparinux sodium] in the treatment of deep vein thrombosis (DVT).

Completed
Phase of Trial: Phase III

Latest Information Update: 05 Apr 2011

At a glance

  • Drugs Idraparinux sodium (Primary) ; Low molecular weight heparins; Vitamin K antagonists
  • Indications Deep vein thrombosis
  • Focus Registrational; Therapeutic Use
  • Acronyms Van Gogh-DVT
  • Sponsors Sanofi
  • Most Recent Events

    • 15 Sep 2006 Status change
    • 05 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top